On August 5th, GeLongHui reported that Xiamen Kingdomway Group (002626.SZ) announced that the company and its wholly-owned subsidiary Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. recently received a patent for the invention of a Coenzyme Q10 fermentation production control method from the National Intellectual Property Office.
The application provides a controlled fermentation production method for Coenzyme Q10. The method may include cultivating a microbial culture of bacteria by providing carbon and oxygen sources, thereby producing bacteria, carbon dioxide and lactic acid containing CoQ10 in the microbial culture. At the same time, in each production stage, maintaining carbon dioxide concentration and/or lactic acid concentration at the predetermined levels.
